Table 1.
Characteristics of included studies.
| First author | Year published | Study location | Study period | Setting | Study population | Sampling strategy | Sample size (M/F) | Age Mean ± SD /Median (Range) | Assessment scales and scores | Data analysis | r/β | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QoL | Scores Mean ± SD /Median (Range) | Resilience | Scores Mean ± SD /Median (Range) | |||||||||||
| Jiang (18) | 2022 | China | Dec. 2019–Dec. 2020 | Hospital | Patients with RIF | – | 95 (0/95) | – | FertiQoL | 68.63 ± 2.63 | CD-RISC | 64.97 ± 11.25 | CA&MLR | −/0.459 |
| Lian (10) | 2022 | China | May.2020–Apr. 2021 | Hospital | Patients with RIF | – | 193 (0/193) | – | FertiQoL | 59.0 (25.0–88.1) | CD-RISC | 28.0 (0.0–100.0) | CA&MLR | 0.60/0.33 |
| Xie (31) | 2022 | China | May.2021–Oct. 2021 | Hospital | Patients with asthenospermia | Convenience | 198 (198/0) | – | FertiQoL | 64.73 ± 11.04 | CD-RISC | 66.41 ± 12.99 | CA&MLR | 0.479/0.426 |
| Zhou (33) | 2022 | China | Jun. 2018–Mar. 2019 | Hospital | Infertile men | – | 335 (335/0) | 31 ± 12 | FertiQoL | 53.03 ± 17.05 | CD-RISC | 63.8 ± 14.8 | CA&MLR | 0.45/0.62 |
| Mo (5) | 2021 | China | Sept.2019–Dec. 2020 | Hospital | Infertile women | – | 400 (0/400) | 30.44 ± 3.53 | FertiQoL | 68.31 ± 12.32 | CD-RISC-10 | 26.37 ± 6.64 | LCA | – |
| Zhou (1) | 2023 | China | Oct. 2019–May. 2021 | Hospital | Infertile patients | Random | 566 (271/295) | – | FertiQoL | 59.74 ± 12.82 | CD-RISC | 59.28 ± 10.13 | CA&MLR | 0.473/0.582 |
| Dong (6) | 2021 | China | Dec. 2019–Dec. 2020 | Hospital | Patients with PCOS | Convenience | 134 (0/134) | 25.46 ± 3.91 | WHOQOL-BREF | 2.56 ± 0.47 | CD-RISC | 62.40 ± 14.48 | CA&MM | 0.592/− |
| Liu (13) | 2020 | China | Nov.2019–Feb. 2020 | Hospital | Patients with RIF | Convenience | 125 (0/125) | – | FertiQoL | 58.18 ± 17.87 | CD-RISC | 65.09 ± 15.14 | CA&MLR | 0.605/0.081 |
| Zhou (14) | 2020 | China | Oct. 2018–Apr. 2019 | Hospital | Infertile patients | Convenience | 100 (25/75) | M:33.52 ± 5.30 F:33.57 ± 6.03 | FertiQoL | 65.72 ± 11.87 | CD-RISC | 59.82 ± 20.78 | CA | 0.434/− |
| Liu (30) | 2019 | China | 2017–2018 | Hospital | Infertile women | Convenience | 548 (0/548) | 32.8 ± 4.42 | FertiQoL | 79.55 ± 16.78 | CD-RISC | 56.99 ± 14.87 | CA&MLR&MM | 0.285/0.208 |
| Zhang (4) | 2019 | China | Apr. 2017–Jun. 2017 | Hospital | Infertile women | – | 116 (0/116) | 33.22 ± 5.42 | FertiQoL | 67.05 ± 14.88 | CD-RISC | 68.84 ± 13.25 | CA | 0.463/− |
| Zhou (34) | 2019 | China | Apr. 2016–Apr. 2017 | Hospital | Infertile women | – | 576 (0/576) | 31.32 ± 5.71 | FertiQoL | 58.54 ± 13.04 | CD-RISC | 60.23 ± 15.20 | CA&MLR | 0.227/0.673 |
| Zhang (35) | 2017 | China | Jun. 2016–Nov. 2016 | Hospital | Infertile women | Convenience | 310 (0/310) | 32.47 ± 4.99 | FertiQoL | 67.47 ± 11.93 | CD-RISC | 66.52 ± 14.32 | CA&MM | 0.434/− |
| Wang (25) | 2022 | China | Oct. 2020–Jan. 2021 | Hospital | Infertile couples | Convenience | 856 (428/428) | M:32.42 ± 5.19 F:31.00 ± 1.24 | FertiQoL | M:67.36 ± 12.44 F:63.21 ± 12.18 | CD-RISC-10 | M:29.78 ± 7.31 F:26.89 ± 7.11 | CA&APIM | 0.499/0.284 a 0.373/− b 0.192/0.104 c 0.143/− d |
| Bhamani (23) | 2022 | Pakistan | 2017–2018 9 months | Hospital | Infertile couples | Purposive | 668 (334/334) | M:35.53 ± 6.67 F:30.87 ± 6.12 | FertiQoL | M:81.66 ± 12.09 F:70.44 ± 15.69 | RS-14 | M:77.64 ± 8.56 F:76.19 ± 8.69 | CA | M&F: 0.161&0.149/− |
| Vatanparast (12) | 2022 | Iran | Mar. 2017–Jun. 2017 | Hospital | Infertile couples | Convenience Simple random | 404 (202/202) | M:35.4 ± 5.1 F:30.9 ± 4.3 | QoLICQ | M:200.2 ± 18.44 F:169.54 ± 16.92 | CD-RISC | M:65.66 ± 15.45 F:61.64 ± 15.34 | CA&MLR | 0.13/0.04 |
| Bhamani (26) | 2020 | Pakistan | – | Hospital | Infertile patients | Purposive | 668 (334/334) | M:35.53 ± 6.72 F:30.87 ± 6.12 | FertiQoL | M:81.58 ± 12.15 F:70.48 ± 15.69 | RS-14 | M:77.64 ± 8.56 F:76.19 ± 8.69 | MLR | M:−/−8.407 F:−/−8.606 |
| Ha (8) | 2020 | South Korea | Aug. 2018–Oct. 2018 | Hospital Website | Infertile couples | Convenience | 300 (150/150) | M:35.81 F:34.03 | FertiQoL | M:76.89 ± 12.80 F:71.70 ± 11.41 | RS | M:120.36 ± 12.31 F:111.26 ± 16.61 | APIM | −/0.201 a −/0.713 b −/0.219 c −/0.351 d |
| Li (16) | 2019 | China | Dec. 2017–Feb. 2018 | Hospital | Infertile women | – | 498 (0/498) | 32.19 ± 3.83 | FertiQoL | 64.54 ± 16.90 | CD-RISC | 59.53 ± 16.18 | CA&MLR | 0.535/0.302 |
| Herrmann (27) | 2011 | Germany | Mar. 2003–Aug. 2003 | Hospital | Infertile couples | – | 398 (199/199) | M:35.6 F:33.0 | WHOQOL-BREF | – | RS | – | CA | M:0.28/− F:0.33/− |
| Royani (29) | 2019 | Iran | Mar. 2015–Jun. 2015 | Hospital | Infertile couples | Convenience | 404 (202/202) | – | QoLICQ | 184 ± 23.36 | CD-RISC | 63.65 ± 15.51 | CA&MLR | 0.13/0.04 |
M, male; F, female; QoL, quality of life; Dec., December; CS, cross-sectional; RIF, repeated implantation failure; FertiQoL, fertility quality of life; CD-RISC, Connor–Davidson resilience scale; MLR, multiple linear regression; CA, correlation analysis; CD-RISC-10, 10-item Connor–Davidson resilience scale; LCA, latent class analysis; PCOS, polycystic ovary syndrome; WHOQOL-BREF, The World Health Organization Quality of Life-BREF; MM, mediation model; APIM, actor–partner interdependence model; RS-14, The 14-item Resilience Scale; RS, the resilience scale; QoLICQ, quality of life questionnaire for infertile couples.
a
FertiQoL and resilience of wives.
b
FertiQoL and resilience of husbands.
c
FertiQoL of husbands and resilience of wives.
d
FertiQoL of wives and resilience of husbands.